Infectious Diseases Organizations

Infectious Diseases Alliance (IDA)

IDAThe Infectious Disease (ID) Alliance is focused on addressing infectious diseases in populations often underserved by our healthcare systems (e.g., people in relatively poor, urban environments, especially children). The Division of Infectious Diseases has built successful partnerships globally to help fight the spread of tuberculosis, malaria, and AIDS in particular. Now, the ID Alliance seeks to build partnerships locally in Cleveland. Working with Cleveland Public Health officials, the ID Alliance is able to identify ID-related needs, and by collaborating with social science experts on campus, address them. Currently, the ID Alliance is developing themes for its work by conducting interviews and small group discussions with stakeholders. The results of these interviews and information from relevant model organizations will be aligned with the strengths of the Division of Infectious Diseases to develop consensus for the ID Alliance.

The goals of the ID Alliance remain to educate the under-served public about infectious disease prevention, seek to understand barriers that this population faces and how they can be overcome, and ultimately, reduce disease occurrence.

Infectious Diseases And Immunology Institute (IDII)

IDII The Infectious Diseases & Immunology Institute (IDII) at Case Western Reserve University was formed in 2011. The multidisciplinary program of the Infectious Diseases & Immunology Institute is built around the outstanding faculty, research and clinical programs at the Case School of Medicine (SOM), other departments in the University and collaborating institutions for training, education and clinical expertise in immunology and infectious diseases. The IDII represents an integrated and interdisciplinary approach to basic and human-oriented research, education and clinical activities of pathogens of national and international health importance and their interactions with host immune responses.

The primary mission of the IDII is to conduct basic, translational, epidemiological and clinical research of molecular biology, immunology, evolution and population dynamics of microbial pathogens and associated host responses and to promote the delivery of the highest quality care of infectious diseases to be linked to the research enterprise. Our three areas of initial focus center around cancer virology, clinical trials and translational molecular diagnostics.